Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
314
-
Total 13F shares, excl. options
-
53.1M
-
Shares change
-
+2.28M
-
Total reported value, excl. options
-
$8.26B
-
Value change
-
+$375M
-
Put/Call ratio
-
0.84
-
Number of buys
-
162
-
Number of sells
-
-136
-
Price
-
$155.50
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2017
383 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q2 2017.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 314 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.1M shares
.
Largest 10 shareholders include PUTNAM INVESTMENTS LLC (8.3M shares), FMR LLC (8.29M shares), VANGUARD GROUP INC (4.68M shares), BlackRock Inc. (3.11M shares), JPMORGAN CHASE & CO (1.41M shares), CADIAN CAPITAL MANAGEMENT, LP (1.39M shares), Bank of New York Mellon Corp (1.38M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1.32M shares), RENAISSANCE TECHNOLOGIES LLC (1.2M shares), and FIL Ltd (1.08M shares).
This table shows the top 314 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.